Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Boehringer Ingelheim
AstraZeneca
Healthtrust
Fish and Richardson
Cerilliant
US Army
Moodys
Teva
Argus Health
Chubb

Generated: August 17, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 208147

« Back to Dashboard
NDA 208147 describes DYANAVEL XR, which is a drug marketed by Tris Pharma Inc and is included in one NDA. It is available from one supplier. There are five patents protecting this drug. Additional details are available on the DYANAVEL XR profile page.

The generic ingredient in DYANAVEL XR is amphetamine. There are fifty-three drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the amphetamine profile page.

Summary for NDA: 208147

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:5
Formulation / Manufacturing:see details

Pharmacology for NDA: 208147

Suppliers and Packaging for NDA: 208147

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
DYANAVEL XR
amphetamine
SUSPENSION, EXTENDED RELEASE;ORAL 208147 NDA Tris Pharma Inc 27808-102 27808-102-01 464 mL in 1 BOTTLE (27808-102-01)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:SUSPENSION, EXTENDED RELEASE;ORALStrengthEQ 2.5MG BASE/ML
Approval Date:Oct 19, 2015TE:RLD:Yes
Patent:► SubscribePatent Expiration:Mar 29, 2029Product Flag?YSubstance Flag?Delist Request?
Patent:► SubscribePatent Expiration:Mar 15, 2027Product Flag?YSubstance Flag?Delist Request?
Patent:► SubscribePatent Expiration:Mar 15, 2027Product Flag?YSubstance Flag?Delist Request?


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Julphar
Medtronic
Chinese Patent Office
Fish and Richardson
QuintilesIMS
Express Scripts
Farmers Insurance
Novartis
US Department of Justice
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot